Simultaneous Investigation of sST2, IL-33, and Caspase-3 Serum Levels in Non-Small Cell Lung Cancer
| dc.authorwosid | Barut, Zerrin/Izq-2308-2023 | |
| dc.contributor.author | Akdeniz, Fatma Tuba | |
| dc.contributor.author | Barut, Zerrin | |
| dc.contributor.author | Avsar, Orcun | |
| dc.contributor.author | Arinc, Sibel | |
| dc.contributor.author | Isbir, Turgay | |
| dc.date.accessioned | 2025-11-15T14:59:10Z | |
| dc.date.available | 2025-11-15T14:59:10Z | |
| dc.date.issued | 2025 | |
| dc.department | Okan University | en_US |
| dc.department-temp | [Akdeniz, Fatma Tuba] Istanbul Okan Univ, Fac Engn & Nat Sci, Dept Genet & Bioengn, Istanbul, Turkiye; [Barut, Zerrin] Antalya Bilim Univ, Fac Dent, Dept Basic Med Sci, Antalya, Turkiye; [Avsar, Orcun] Hitit Univ, Fac Arts & Sci, Dept Mol Biol & Genet, Corum, Turkiye; [Arinc, Sibel] Sureyyapasa Training & Res Hosp Chest Dis & Thorac, Istanbul, Turkiye; [Sbir, Turgay] Yeditepe Univ, Inst Hlth Sci, Dept Mol Med, 26 Agustos Campus,Kayisdagi Cad 324A, TR-34755 Istanbul, Turkiye | en_US |
| dc.description.abstract | <bold>Background/Aim:</bold> Non-small cell lung cancer (NSCLC) is a type of lung cancer with a high mortality rate. Many molecular and biochemical mechanisms are involved in its development, among which the suppression of tumorigenicity-2 protein (ST2) signaling pathway. Soluble ST2 (sST2) competes with transmembrane ST2 (ST2 ligand) for IL-33 binding. Activation of IL-33/ST2 pathway leads to M2 macrophage polarization, which promotes tumor progression. Since Caspase-3 is implicated in the regulation of IL-33 activity, the present study aimed to analyze the serum levels of IL-33, sST2, and caspase-3 in non-small cell lung cancer patients, compare them with control samples, and simultaneously investigate their predictive capacity. <bold>Materials and Methods:</bold> In this study, sST2 protein, IL-33, and caspase-3 levels were investigated using the ELISA method in serum samples collected from 25 patients diagnosed with non-small cell lung cancer and 25 completely healthy volunteer individuals. In the study, receiver operating characteristic (ROC) analysis was performed to evaluate the diagnostic power of the biomarkers. <bold>Results:</bold> Serum IL-33 levels were found to be significantly elevated in patients compared to the control group (p<0.0001). Similarly, the patient group showed significantly higher caspase-3 serum levels than the control group (p<0.030). While sST2 serum levels were higher in the patient group, the difference did not reach statistical significance. The ROC analysis for IL-33 showed an area under the curve (AUC) value of 0.838 [95% confidence interval (CI)=0.725-0.952, p<0.05], indicating that IL-33 is good diagnostic capability for NSCLC. The AUC value for Caspase-3 was 0.678 (95% CI=0.525-0.832, p=0.023), while for sST2, the AUC value was 0.499 (95% CI=0.333-0.665, p>0.05). <bold>Conclusion:</bold> NSCLC patients are characterized by increased IL-33 and caspase-3 serum levels. These findings suggest that these markers could serve as valuable diagnostic and prognostic indicators, in addition to being potential therapeutic targets. | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded | |
| dc.identifier.doi | 10.21873/invivo.14127 | |
| dc.identifier.endpage | 3286 | en_US |
| dc.identifier.issn | 0258-851X | |
| dc.identifier.issn | 1791-7549 | |
| dc.identifier.issue | 6 | en_US |
| dc.identifier.pmid | 41167693 | |
| dc.identifier.scopus | 2-s2.0-105020449269 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 3278 | en_US |
| dc.identifier.uri | https://doi.org/10.21873/invivo.14127 | |
| dc.identifier.volume | 39 | en_US |
| dc.identifier.wos | WOS:001608235100017 | |
| dc.identifier.wosquality | Q3 | |
| dc.language.iso | en | en_US |
| dc.publisher | International Institute of Anticancer Research | en_US |
| dc.relation.ispartof | In Vivo | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Non-Small Cell Lung Cancer | en_US |
| dc.subject | SST2 Protein | en_US |
| dc.subject | IL-33 | en_US |
| dc.subject | Caspase-3 | en_US |
| dc.title | Simultaneous Investigation of sST2, IL-33, and Caspase-3 Serum Levels in Non-Small Cell Lung Cancer | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article |